Bora Pharmaceuticals Capabilities Update October 2026: Small Molecule Drug Product

Managing a diverse pharmaceutical pipeline can require multiple manufacturing technologies, scales and supply strategies. Bora Pharmaceuticals combines development and commercial capacity across oral solids, non-sterile liquids, semi-solids, ophthalmics, sterile fill-finish and biologics, providing options for programs with very different requirements.

Its global network also offers overlapping capabilities that can support business continuity, regional manufacturing strategies and expansion into new markets. Investments in sterile filling, high-speed production, high-potency processing and packaging are adding further flexibility, while development and technology-transfer teams can support both new programs and established processes. For companies looking to reduce the complexity of managing multiple manufacturing partners, these capabilities create opportunities to keep development, scale-up, manufacturing and packaging within a broader integrated network.

Watch the webinar to explore Bora’s capacity and capabilities across clinical and commercial manufacturing.